Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2024
Nine provinces approve accelerated public reimbursement of diffuse large B-cell lymphoma treatment under new early access process
21 October 2024 - AbbVie today announced that nine provinces have provided accelerated public coverage of Epkinly. ...
Posted by Michael Wonder on 08 Mar 2023
Jazz Pharmaceuticals secures eight additional provincial reimbursements for Vyxeos for treatment of adults with newly diagnosed therapy-related acute myeloid leukaemia or acute myeloid leukaemia with myelodysplasia-related changes
8 March 2023 - Jazz Pharmaceuticals announced today that Vyxeos (daunorubicin and cytarabine liposome for injection) is now included on eight ...
Posted by Michael Wonder on 21 Apr 2022
Astellas announces reimbursement for Xospata (gilteritinib) in most provinces for patients with relapsed or refractory acute myeloid leukaemia with a FLT3 mutation
21 April 2022 - Having access to an additional treatment option offers hope for Canadian adult AML patients with relapsed ...
Posted by Michael Wonder on 24 Feb 2022
Valeo Pharma obtains public reimbursement for Enerzair Breezhaler and Atectura Breezhaler in Ontario, Manitoba and New Brunswick
24 February 2022 - Private insurance coverage across Canada exceeds 90%. ...
Posted by Michael Wonder on 14 Feb 2021
Manitoba is Canada’s first province to nab home grown vaccine
12 February 2021 - Manitoba to buy 2 million doses of yet to be approved vaccine. ...
Posted by Michael Wonder on 12 Mar 2020
AbbVie announces new formulary listings for Skyrizi in the treatment of moderate to severe plaque psoriasis
12 March 2020 - Non-Insured Health Benefits program lists Skyrizi on its formulary effective 21 February 2020. ...
Posted by Michael Wonder on 04 Sep 2019
NDP promises to restore special drugs program
4 September 2019 - Province paid deductible for chronic patients from 1968 to 2018. ...
Posted by Michael Wonder on 04 Sep 2019
Manitoba Liberals promise to opt into national Pharmacare program
4 September 2019 - Liberals say Pallister won't sign onto such a program but Tories say they've been trying to get ...